My hon. Friend the Under-Secretary of State has dealt with the matter once. I repeat that the truth of the matter is that the drug and therapeutics committee of that hospital took an entirely sensible view that against the background of doubts about the drug—[Interruption.] The hon. Gentleman will find that at the time the meeting took place the committee believed that the drug had a product licence whereas in fact it did not. Other, more expensive drugs are still being prescribed in the hospital.

One doctor breaking ranks with his colleagues like that and taking an individual case is exactly the wrong way to make decisions about such matters and puts patients in a difficult position. We must stand on the clinical decisions of the committees in the hospitals. They have always had difficult decisions to make about alternative treatments. I am sure that the doctors in that hospital took the right decision, which was not to spend a large sum of money on a drug of doubtful efficacy.